Operating income flipped from a loss to $12.5 million profit.
Gross profit margin increased from 13.3% to 16.9%.
Repurchased $35.7 million of common stock in Q1.
Announced $190 million acquisition of Calabrian sulfur business.
Completed sale of Advanced Materials & Catalysts business.
The Q1 2026 filing presents a company at a crossroads between a successful strategic pivot and a high-leverage risk profile. On one hand, the shift toward a focused sulfuric acid ecosystem has yielded immediate results in the form of positive net income from continuing operations and a significant jump in Adjusted EBITDA. The ability to flip from operating losses to a $12.5 million profit demonstrates that the core business is fundamentally cash-generative and capable of scaling. However, the sustainability of this turnaround depends on management's ability to maintain a delicate balance between growth-oriented M&A and debt service. The aggressive return of capital through share repurchases during a period of high debt and pending acquisitions is a bold move that could either signal extreme confidence in cash flows or a risky depletion of liquidity. Investors will likely focus on the integration of the Calabrian assets and whether the company can push gross margins toward industry-standard levels without compromising its balance sheet stability.